Trust the Evidence

Trust the Evidence

Share this post

Trust the Evidence
Trust the Evidence
The Story of Influenza Antivirals: Part 2
Copy link
Facebook
Email
Notes
More

The Story of Influenza Antivirals: Part 2

The Emergence of Tamiflu

Tom Jefferson's avatar
Carl Heneghan's avatar
Tom Jefferson
and
Carl Heneghan
Mar 21, 2023
∙ Paid
56

Share this post

Trust the Evidence
Trust the Evidence
The Story of Influenza Antivirals: Part 2
Copy link
Facebook
Email
Notes
More
3
Share

Share

The first Neuraminidase inhibitor (NI) to be licensed by its manufacturer Glaxo Wellcome and SmithKline Beecham (who went on to form GSK) in 1999 was zanamivir (Relenza), an inhaled diskhaler powder. This was closely followed by oseltamivir (patented by Gilead Science and marketed by Roche) in late 1999: a capsule for oral consumption, usually three tim…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Carl Heneghan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More